| Literature DB >> 33547926 |
Jose M El-Asmar1, Muhieddine Labban1, Albert El-Hajj2.
Abstract
PURPOSE: To evaluate the feasibility of telementoring for aquablation by comparing the outcomes of onsite versus telemetry proctoring.Entities:
Keywords: Benign prostatic hyperplasia; Remote consultation; Robotics; Technology; Telemedicine
Mesh:
Substances:
Year: 2021 PMID: 33547926 PMCID: PMC7866960 DOI: 10.1007/s00345-021-03603-x
Source DB: PubMed Journal: World J Urol ISSN: 0724-4983 Impact factor: 4.226
Fig. 1Proximie platform. 1. Main computer system 2. Audio/Video System 3. Camera with optical zoom 4. Remote Control 5. Secondary screen
Fig. 2Setup of Telemetry assistance during aquablation
Baseline demographics, comorbities, and serum markers for patients undergoing aquablation factored by on-site proctoring versus telemetry assisted procedures
| Variable | On-site Proctoring ( | Telementoring ( | |
|---|---|---|---|
| Age | 69.4 ± 7.7 (69) | 66.2 ± 8.0 (64) | 0.072 |
| BMI | 28.3 ± 4.2 (27.2) | 27.3 ± 3.4 (26.6) | 0.419 |
| ASA ≥ 2 | 31 (81.6%) | 15 (71.4%) | 0.513 |
| General anesthesia | 8 (21.1%) | 16 (76.2%) | < 0.0001 |
| INR | 1.0 ± 0.1 (1.0) | 1.0 ± 0.1 (1.0) | 0.071 |
| Hemoglobin | 14.4 ± 1.4 (14.4) | 14.4 ± 1.4 (14.8) | 0.791 |
| PSA | 4.2 ± 4.3 (3.1) | 4.2 ± 2.7 (3.8) | 0.313 |
| Prostate size (g) | 71.1 ± 36.5 (62.1) | 71.8 ± 19.8 (73.7) | 0.605 |
| In retention | 8 (21.1%) | 6 (28.6%) | 0.538 |
| Cautery use | 18 (47.4%) | 17 (81.0%) | 0.012 |
ASA American Society of Anesthesiology class; INR international normalized ratio; PSA Prostate Specific Antigen
Comparison of perioperative outcomes in aquablation between on-site proctering versus telementory assistance
| Perioperative surgical outcomes | On-site Proctoring ( | Telementoring ( | |
|---|---|---|---|
| Operative time (min) | 49.0 ± 20.8 (47.5) | 47.7 ± 16.1 (46.0) | 0.824 |
| Length of stay (days) | 2.2 ± 1.0 (2.0) | 2.2 ± 0.8 (2.0) | 0.662 |
| Length of catheterization (days) | 1.7 ± 1.1 (2.0) | 2.8 ± 4.2 (2.0) | 0.473 |
| Prior to discharge recatheterization | 5 (13.2%) | 4 (19.0%) | 0.708 |
| Re-hospitalization | 1 (2.6%) | 2 (9.5%) | 0.218 |
| 3-month adverse events | 8 (21.1%) | 9 (42.9%) | 0.08 |
| Clavien-Dindo Grade I | |||
| Acute urinary retention | 2 (25.0%) | 3 (37.5%) | |
| Overactive bladder | 1 (12.5%) | 2 (25.0%) | |
| Hemorrhoid thrombosis | 1 (12.5%) | – | |
| Clavien-Dindo Grade II | |||
| Urinary tract infection | 2 (25.0%) | 1 (12.5%) | |
| Deep vein thrombosis | – | 1 (12.5%) | |
| Capsular perforation | – | 1 (12.5%) | |
| Clavien-Dindo Grade IIIa | |||
| Decreased urinary flow | 1 (12.5%) | 1 (12.5%) | |
| Clavien-Dindo Grade IIIb | |||
| Urethral stricture | 1 (12.5%) | ||
Fig. 3Comparison of functional outcomes between onsite and telemetry proctored procedures